Chorea-acanthocytosis (ChAc) is an uncommon autosomal recessive disorder due to mutations of the VPS13A gene, which encodes for the membrane protein chorein. ChAc presents with progressive limb and orobuccal chorea, but there is often a marked dysexecutive syndrome. ChAc may first present with neuropsychiatric disturbance such as obsessive-compulsive disorder (OCD), suggesting a particular role for disruption to striatal structures involved in non-motor frontostriatal loops, such as the head of the caudate nucleus. Two previous studies have suggested a marked reduction in volume in the caudate nucleus and putamen, but did not examine morphometric change. We investigated morphometric change in 13 patients with genetically or biochemically confirmed ChAc and 26 age-and gender-matched controls. Subjects underwent magnetic resonance imaging and manual segmentation of the caudate nucleus and putamen, and shape analysis using a non-parametric spherical harmonic technique. Both structures showed significant and marked reductions in volume compared with controls, with reduction greatest in the caudate nucleus. Both structures showed significant shape differences, particularly in the head of the caudate nucleus. No significant correlation was shown between duration of illness and striatal volume or shape, suggesting that much structural change may have already taken place at the time of symptom onset. Our results suggest that striatal neuron loss may occur early in the disease process, and follows a dorsal-ventral gradient that may correlate with early neuropsychiatric and cognitive presentations of the disease.
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Introduction
The neuroacanthocytoses are a group of disorders that present with neurological and psychiatric manifestations, and acanthocytes, spiculated red blood cells. Chorea-acanthocytosis (ChAc; MIM 200150) is an autosomal recessive disorder associated with mutations or deletions in the VPS13A gene on chromosome 9q. This gene codes for the membrane protein chorein (Ueno et al., 2001; Rampoldi et al., 2002) , which is strongly expressed in the brain (Dobson-Stone et al., 2002) . Loss of function of chorein appears to affect basal ganglia neurons, especially those in the caudate and putamen (Bader et al., 2008) . Onset of neurological disturbance in ChAc is usually between ages 25 and 45, commonly with limb chorea that may be indistinguishable from Huntington's disease (Dobson-Stone et al., 2002) , but also with distinctive lingual feeding dystonia (Bader et al., 2010) . Identification and sequencing of the VPS13A gene (Rampoldi et al., 2001; Ueno et al., 2001 ) have enabled definitive diagnosis of ChAc and differentiation from related neuroacanthocytosis syndromes such as McLeod syndrome (Danek et al., 2005) . Diagnosis have been facilitated by the development of a Western blot screening test for decreased or absent levels of chorein (Dobson-Stone et al., 2004) .
Histopathologically, the relatively rare ChAc cases with confirmed VPS13A mutations have shown marked striatal neuronal loss with reactive astrocytic gliosis, particularly in the head of the caudate nucleus, with the globus pallidus less affected; and with minimal changes in the thalamus and substantia nigra, with the cortex almost universally spared (Bader et al., 2008) . Magnetic resonance imaging (MRI) findings in established ChAc cases mirror these findings, showing Psychiatry Research: Neuroimaging 192 (2011) 29-36 
